カテゴリー： 世界, 医療/バイオ, Grand View Research

miRNAシーケンス＆アッセイのグローバル市場2023-2030：癌、ポリグルタミン疾患、自己免疫疾患、統合失調症、その他

【英語タイトル】miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report By Product & Service (Library Preparation Kits), By Technology, By Workflow, By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NVB026）・商品コード：GRV23NVB026
・発行会社（調査会社）：Grand View Research
・発行日：2023年10月25日
・ページ数：120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：バイオテクノロジー
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

miRNAシーケンス＆アッセイ市場の成長と動向
Grand View Research, Inc.の最新レポートによると、世界のmiRNAシーケンス＆アッセイ市場規模は、2023年から2030年にかけて13.3%のCAGRを記録し、2030年までに8億2350万米ドルに達する見込みです。例えば、miRNAは癌（子宮頸がん、卵巣がん、乳がん）、敗血症、心血管疾患、神経系疾患の予後や診断のバイオマーカーとして効率的に使用できることが、さまざまな調査研究で示されています。このように、miRNAの配列解析は、臨床疾患における遺伝子制御解析に大きく利用されています。例えば、2022年3月にfrontiers誌に掲載された論文では、血液ベースのmiRNAバイオマーカーが脳ベースのmiRNA発現との相関に使用できると述べられています。

COVID-19のパンデミックは、コロナウイルスの存在を特定するためのmiRNAの利用を強化しました。miRNAバイオマーカーは、COVID-19の重症度を示し、診断するために応用される可能性があります。miRNAは免疫反応、ウイルス増殖、感染細胞の複製、心血管機能障害に重要な役割を果たしています。さらに、COVID-19患者から回収された血漿には抗体と抗ウイルスmiRNAが豊富に含まれています。COVID-19感染患者の治療に活用されています。このため、ウイルスだけでなく患者からのmiRNA配列解析に焦点を当てた研究が増加しています。

PerkinElmer Inc.、Illumina, Inc.、Qiagenなどの著名企業は、いくつかの臨床用途向けに革新的なシーケンス製品を提供しています。さらに、これらの企業は、研究研究におけるシーケンスアプリケーションを拡大するため、研究機関といくつかの戦略的イニシアティブを締結しています。例えば、韓国のバイオ医薬品企業であるBIORCHESTRAは、2022年1月にSK Biopharmaceuticalsと提携契約を締結し、miRNAを標的とする新規治療化合物の研究開発を加速しています。

市場の主要プレーヤーは、高い特異性と再現性を備えた新しいツール、機器、キットの開発に携わっており、これが市場の成長を後押ししています。例えば、2019年10月、TriLink BioTechnologies社は、CleanTagキット用の2つのプライマーセットを発表しました。サーモフィッシャーサイエンティフィックのシーケンサープラットフォームは、これらの新しいIon Torrent Convertバーコードプライマーセットを使用して小分子RNAライブラリを調製することができます。このような発売は市場の成長を後押しすると期待されています。

miRNAシーケンス＆アッセイ市場レポートハイライト

- 製品分野が2022年に約80%の最大収益シェアで市場を支配しました。これは、特定の用途向けに幅広い消耗品、キット、機器を提供する複数の主要企業の存在によるものです。

- 技術別では、合成によるシーケンシングセグメントが2022年に32%超の最大収益シェアで市場を支配しました。これは、迅速なターンアラウンドタイム、高感度、高スループットによるものです。さらに、腫瘍組織の変異検出において重要な役割を果たしており、個別化治療の開発に役立っています。

- ワークフロー別では、シーケンシングセグメントが2022年に50%を超える最大の収益シェアで市場を支配し、ワークフローの中で最も重要なステップであることから、予測期間中のCAGRは14.1%と最も速い成長が見込まれています。生物学的研究やいくつかの疾患診断において重要な研究ツールとなっています。

- 用途別では、癌分野が市場を支配し、2022年には35%以上の最大の収益シェアを占めました。新しい治療法を開発するために癌の予後と診断を研究するバイオマーカーとしてmiRNAを使用する癌のいくつかの進行中の研究が、このセグメントの成長に寄与しています。

- 最終用途別では、研究機関および学術機関が市場を支配し、2022年には50%を超える最大の収益シェアを占めました。この成長は、学術機関がmiRNAシーケンス技術を使用して行う研究開発研究の増加に起因しています。

- アジア太平洋地域は予測期間中、CAGR 15.4%と最も速い成長が見込まれています。これは、医療インフラの成長、対象人口の増加、アンメット・クリニカル・ニーズの高さによるものです。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. miRNAシーケンス＆アッセイの市場変数・傾向・範囲
第4章. miRNAシーケンス＆アッセイの世界市場：製品＆サービス別予測・傾向分析
第5章. miRNAシーケンス＆アッセイの世界市場：技術別予測・傾向分析
第6章. miRNAシーケンス＆アッセイの世界市場：ワークフロー別予測・傾向分析
第7章. miRNAシーケンス＆アッセイの世界市場：用途別予測・傾向分析
第8章. miRNAシーケンス＆アッセイの世界市場：最終用途別予測・傾向分析
第9章. miRNAシーケンス＆アッセイの世界市場：地域別予測・傾向分析
第10章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product & Service
1.1.2. Technology
1.1.3. Workflow
1.1.4. Application
1.1.5. End use
1.1.6. Regional scope
1.1.7. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product & service outlook
2.2.2. Technology outlook
2.2.3. Workflow outlook
2.2.4. Application outlook
2.2.5. End use outlook
2.2.6. Regional outlook
2.3. Competitive Insights
Chapter 3. miRNA Sequencing And Assay Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. miRNA Sequencing And Assay Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. miRNA Sequencing And Assay: Product & Service Estimates & Trend Analysis
4.1. miRNA Sequencing And Assay Market: Key Takeaways
4.2. miRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Products
4.3.1. Products market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.2. Library preparation kits
4.3.2.1. Library preparation kits market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.3. Sequencing consumables
4.3.3.1. Sequencing consumables market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.4. Instruments
4.3.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Services
4.4.1. Services market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. MiRNA Sequencing And Assay: Technology Estimates & Trend Analysis
5.1. MiRNA Sequencing And Assay Market: Key Takeaways
5.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Sequencing by synthesis
5.3.1. Sequencing by synthesis market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Sequencing By Oligonucleotide Ligation and Detection (SOLiD)
5.4.1. Sequencing by oligonucleotide ligation and detection (SOLiD) market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Nanopore Sequencing
5.5.1. Nanopore sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Sanger Sequencing
5.6.1. Sanger sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Single molecule real – time (SMRT) Sequencing
5.7.1. Single molecule real – time (SMRT) sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. MiRNA Sequencing And Assay: Workflow Estimates & Trend Analysis
6.1. MiRNA Sequencing And Assay Market: Key Takeaways
6.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Library Preparation
6.3.1. Library preparation market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Sequencing
6.4.1. Sequencing market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Data analysis & storage
6.5.1. Data analysis & storage market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. MiRNA Sequencing And Assay: Application Estimates & Trend Analysis
7.1. MiRNA Sequencing And Assay Market: Key Takeaways
7.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Cancer
7.3.1. Cancer market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Polyglutamine Diseases
7.4.1. Polyglutamine diseases market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Autoimmune Disease
7.5.1. Autoimmune disease market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Schizophrenia
7.6.1. Schizophrenia market estimates and forecasts, 2018 to 2030 (USD Million)
7.7. Others
7.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. MiRNA Sequencing And Assay: End Use Estimates & Trend Analysis
8.1. MiRNA Sequencing And Assay Market: Key Takeaways
8.2. MiRNA Sequencing And Assay Market: Movement & Market Share Analysis, 2022 & 2030
8.3. Pharmaceutical & Biotechnology Industry
8.3.1. Pharmaceutical & biotechnology industry market estimates and forecasts, 2018 to 2030 (USD Million)
8.4. Research & Academic Institutes
8.4.1. Research & academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
8.5. Others
8.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 9. MiRNA Sequencing And Assay: Regional Estimates & Trend Analysis
9.1. Regional Outlook
9.2. MiRNA Sequencing And Assay Market by Region: Key Takeaway
9.3. North America
9.3.1. North America market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.3.2. U.S.
9.3.2.1. U.S. market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.3.3. Canada
9.3.3.1. Canada market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.4. Europe
9.4.1. Europe market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.4.2. UK
9.4.2.1. UK market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.4.3. Germany
9.4.3.1. Germany market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.4.4. France
9.4.4.1. France market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.4.5. Italy
9.4.5.1. Italy market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.4.6. Spain
9.4.6.1. Spain market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.4.7. Sweden
9.4.7.1. Sweden market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.4.8. Norway
9.4.8.1. Norway market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.4.9. Denmark
9.4.9.1. Denmark market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.5. Asia Pacific
9.5.1. Asia Pacific market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.5.2. Japan
9.5.2.1. Japan market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.5.3. China
9.5.3.1. China market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.5.4. India
9.5.4.1. India market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.5.5. Australia
9.5.5.1. Australia market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.5.6. Thailand
9.5.6.1. Thailand market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.5.7. South Korea
9.5.7.1. South Korea market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.6. Latin America
9.6.1. Latin America market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.6.2. Brazil
9.6.2.1. Brazil market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.6.3. Mexico
9.6.3.1. Mexico market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.6.4. Argentina
9.6.4.1. Argentina market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.7. MEA
9.7.1. MEA market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.7.2. Saudi Arabia
9.7.2.1. Saudi Arabia market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.7.3. South Africa
9.7.3.1. South Africa market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.7.4. UAE
9.7.4.1. UAE market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
9.7.5. Kuwait
9.7.5.1. Kuwait market estimates and forecasts, 2018 – 2030 (USD Million) (Revenue, USD Million)
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Market Participant Categorization
10.2.1. Thermo Fisher Scientific, Inc.
10.2.1.1. Company overview
10.2.1.2. Financial performance
10.2.1.3. Product benchmarking
10.2.1.4. Strategic initiatives
10.2.2. Illumina, Inc.
10.2.2.1. Company overview
10.2.2.2. Financial performance
10.2.2.3. Product benchmarking
10.2.2.4. Strategic initiatives
10.2.3. QIAGEN
10.2.3.1. Company overview
10.2.3.2. Financial performance
10.2.3.3. Product benchmarking
10.2.3.4. Strategic initiatives
10.2.4. PerkinElmer, Inc
10.2.4.1. Company overview
10.2.4.2. Financial performance
10.2.4.3. Product benchmarking
10.2.4.4. Strategic initiatives
10.2.5. Abcam plc
10.2.5.1. Company overview
10.2.5.2. Financial performance
10.2.5.3. Product benchmarking
10.2.5.4. Strategic initiatives
10.2.6. New England Biolabs
10.2.6.1. Company overview
10.2.6.2. Financial performance
10.2.6.3. Product benchmarking
10.2.6.4. Strategic initiatives
10.2.7. Takara Bio Inc.
10.2.7.1. Company overview
10.2.7.2. Financial performance
10.2.7.3. Product benchmarking
10.2.7.4. Strategic initiatives
10.2.8. Lexogen GmbH
10.2.8.1. Company overview
10.2.8.2. Financial performance
10.2.8.3. Product benchmarking
10.2.8.4. Strategic initiatives
10.2.9. Norgen Biotek Corp.
10.2.9.1. Company overview
10.2.9.2. Financial performance
10.2.9.3. Product benchmarking
10.2.9.4. Strategic initiatives
10.2.10. Maravai LifeSciences
10.2.10.1. Company overview
10.2.10.2. Financial performance
10.2.10.3. Product benchmarking
10.2.10.4. Strategic initiatives
10.2.11. HTG Molecular Diagnostics, Inc.
10.2.11.1. Company overview
10.2.11.2. Financial performance
10.2.11.3. Product benchmarking
10.2.11.4. Strategic initiatives
10.2.12. Meridian Bioscience, Inc.
10.2.12.1. Company overview
10.2.12.2. Financial performance
10.2.12.3. Product benchmarking
10.2.12.4. Strategic initiatives
10.2.13. System Biosciences, LLC
10.2.13.1. Company overview
10.2.13.2. Financial performance
10.2.13.3. Product benchmarking
10.2.13.4. Strategic initiatives

List of Tables

Table 1 List of abbreviations
Table 2 North America miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 3 North America miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 4 North America miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 5 North America miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 6 North America miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 7 North America miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
Table 8 U.S. miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 9 U.S. miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 10 U.S. miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 11 U.S. miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 12 U.S. miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 13 Canada miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 14 Canada miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 15 Canada miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 16 Canada miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 17 Canada miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 18 Europe miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 19 Europe miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 20 Europe miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 21 Europe miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 22 Europe miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 23 Europe miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
Table 24 Germany miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 25 Germany miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 26 Germany miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 27 Germany miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 28 Germany miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 29 UK miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 30 UK miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 31 UK miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 32 UK miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 33 UK miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 34 France miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 35 France miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 36 France miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 37 France miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 38 France miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 39 Italy miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 40 Italy miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 41 Italy miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 42 Italy miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 43 Italy miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 44 Spain miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 45 Spain miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 46 Spain miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 47 Spain miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 48 Spain miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 49 Sweden miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 50 Sweden miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 51 Sweden miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 52 Sweden miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 53 Sweden miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 54 Norway miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 55 Norway miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 56 Norway miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 57 Norway miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 58 Norway miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 59 Denmark miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 60 Denmark miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 61 Denmark miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 62 Denmark miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 63 Denmark miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 64 Asia Pacific miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 65 Asia Pacific miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 66 Asia Pacific miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 67 Asia Pacific miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 68 Asia Pacific miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 69 Asia Pacific miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
Table 70 China miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 71 China miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 72 China miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 73 China miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 74 China miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 75 Japan miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 76 Japan miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 77 Japan miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 78 Japan miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 79 Japan miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 80 India miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 81 India miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 82 India miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 83 India miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 84 India miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 85 Australia miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 86 Australia miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 87 Australia miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 88 Australia miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 89 Australia miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 90 Thailand miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 91 Thailand miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 92 Thailand miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 93 Thailand miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 94 Thailand miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 95 South Korea miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 96 South Korea miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 97 South Korea miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 98 South Korea miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 99 South Korea miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 100 Latin America miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 101 Latin America miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 102 Latin America miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 103 Latin America miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 104 Latin America miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 105 Latin America miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
Table 106 Brazil miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 107 Brazil miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 108 Brazil miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 109 Brazil miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 110 Brazil miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 111 Mexico miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 112 Mexico miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 113 Mexico miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 114 Mexico miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 115 Mexico miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 116 Argentina miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 117 Argentina miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 118 Argentina miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 119 Argentina miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 120 Argentina miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 121 Middle East and Africa miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 122 Middle East and Africa miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 123 Middle East and Africa miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 124 Middle East and Africa miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 125 Middle East and Africa miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 126 Middle East and Africa miRNA sequencing and assay market, by region, 2018 - 2030 (USD Million)
Table 127 South Africa miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 128 South Africa miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 129 South Africa miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 130 South Africa miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 131 South Africa miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 137 UAE miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 138 UAE miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 139 UAE miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 140 UAE miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 141 UAE miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)
Table 142 Kuwait miRNA sequencing and assay market, by product & service, 2018 - 2030 (USD Million)
Table 143 Kuwait miRNA sequencing and assay market, by technology, 2018 - 2030 (USD Million)
Table 144 Kuwait miRNA sequencing and assay market, by workflow, 2018 - 2030 (USD Million)
Table 145 Kuwait miRNA sequencing and assay market, by application, 2018 - 2030 (USD Million)
Table 146 Kuwait miRNA sequencing and assay market, by end use, 2018 - 2030 (USD Million)

★調査レポート[miRNAシーケンス＆アッセイのグローバル市場2023-2030：癌、ポリグルタミン疾患、自己免疫疾患、統合失調症、その他] (コード：GRV23NVB026)販売に関する免責事項を必ずご確認ください。
★調査レポート[miRNAシーケンス＆アッセイのグローバル市場2023-2030：癌、ポリグルタミン疾患、自己免疫疾患、統合失調症、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の二重特異性抗体市場2023-2030：疾患別（癌、炎症性・自己免疫疾患、その他）、地域別
  • 世界の慢性疾患管理治療薬＆装置技術市場2023-2030：疾患別（心血管疾患（CVD）、糖尿病、がん、慢性呼吸器疾患、慢性腎臓病、神経疾患、その他（自己免疫疾患、胃腸疾患等））、治療別、装置別、地域別
  • 世界のエピジェネティクス市場2023-2030：製品別（装置、キット＆試薬、その他）、用途別（がん、自己免疫疾患、代謝性疾患、中枢神経/疼痛疾患、心血管疾患）、技術別（メチル化、アセチル化、リン酸化、その他技術）、地域別
  • 世界の自己注射器市場2023-2030：製品別（自動注射器、ペン型注射器、ウェアラブル注射器、無針注射器）、使用別（使い捨て、再利用可能）、用途別（がん、自己免疫疾患、ホルモン疾患、疼痛管理、その他）、地域別
  • 世界のオランザピン市場2023-2030：用途別（統合失調症、双極性障害、その他）、投与経路別（経口、非経口）、流通チャネル別（病院薬局、ドラッグストア・小売薬局、オンラインプロバイダー）、地域別
  • 世界のオランザピン市場2021-2031：用途別（統合失調症、双極性障害、その他）、投与経路別、流通チャネル別
  • 世界のビタミンD療法市場2023-2030：投与経路別（経口剤、非経口剤）、購入形態別（OTC医薬品、処方薬）、用途別（骨粗鬆症、くる病、皮膚疾患、筋力低下、自己免疫疾患、その他の用途）、年齢層別（小児、成人、高齢者）、地域別
  • プライマリケアPOC診断のグローバル市場（2023年-2030年）：感染症、グルコース検査、自己免疫疾患、Hb1Ac検査、不妊症、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆